ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers.

Razelle Kurzrock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.